1-(1-甲基-1H-吲哚-5-基)-3-(吡啶-3-基)脲盐酸盐
- CAS号:143797-62-0
- 英文名:SB 200646 HYDROCHLORIDE
- 中文名:1-(1-甲基-1H-吲哚-5-基)-3-(吡啶-3-基)脲盐酸盐
- CBNumber:CB6497473
- 分子式:C15H14N4O.ClH
- 分子量:302.763
- MOL File:143797-62-0.mol
- 储存条件 :Inert atmosphere,Room Temperature
- 溶解度 :DMSO: ~26 mg/mL, soluble
- 形态 :solid
- 颜色 :pale yellow
1-(1-甲基-1H-吲哚-5-基)-3-(吡啶-3-基)脲盐酸盐性质、用途与生产工艺
- 生物活性 SB-200646A 是第一个对 5-HT2B/2C 的选择性超过 5-HT2A 的拮抗剂,5-HT2B,5-HT2C 和 5-HT2A 的 pKi 值分别为 7.5、6.9 和 5.2。SB-200646A 具有口服活性,在体内具有电生理和抗焦虑特性。
-
靶点
5-HT 2B Receptor
7.5 (pKi)
5-HT 2C Receptor
6.9 (pKi)
5-HT 2A Receptor
5.2 (pKi)
-
体外研究
SB200646A (4 μM) abolishes the ethanol-induced increase in miniature inhibitory postsynaptic current (mIPSC) frequency and had no effect on basal mIPSC frequency.
-
体内研究
SB-200646A (20 mg/kg; intravenous injection; daily; for 21 days; male albino Sprague-Dawley rats) treatment significantly decreases the number of spontaneously active ventral tegmental area (VTA) dopaminergic neurons.
The i.v. administration of 4-16 mg/kg of SB-200646A significantly increases the firing rate and % events as bursts in spontaneously active VTA dopaminergic neurons and significantly increases the % events as burst in substantia nigra pars compacta (SNC) dopaminergic neurons.Animal Model: Male albino Sprague-Dawley rats (200-225 g at the beginning of treatment and 300-350 g at the time of the experiment) Dosage: 20 mg/kg Administration: Intravenous injection; daily; for 21 days Result: Significantly decreased the number of spontaneously active ventral tegmental area (VTA) dopaminergic neurons.
- 更新日期:2024/11/08
- 产品编号:HY-103129
- 产品名称:1-(1-甲基-1H-吲哚-5-基)-3-(吡啶-3-基)脲盐酸盐 SB-200646A
- CAS编号:143797-62-0
- 包装:5mg
- 价格:700元
- 更新日期:2024/11/08
- 产品编号:HY-103129
- 产品名称:1-(1-甲基-1H-吲哚-5-基)-3-(吡啶-3-基)脲盐酸盐 SB-200646A
- CAS编号:143797-62-0
- 包装:10mM * 1mLin DMSO
- 价格:770元
- 公司名称:TOCRIS-US
- 联系电话:--
- 电子邮件:customerservice@tocris.co.uk
- 国家:英国
- 产品数:5726
- 优势度:77
- 447410-57-3 SB-3CT SBI-115; SBI 115; SBI115 4-(4-氟苯基)-2-(4-羟基苯基)-5-(4-吡啶基)-1H-咪唑 SB-431542 SB 743921; (R)-N-(3-AMINOPROPYL)-N-(1-(3-BENZYL-7-CHLORO-4-OXO-4H-CHROMEN-2-YL)-2-METHYLPROPYL)-4-METHYLBENZAMIDE HYDROCHLORIDE 5-[2-[4-[2-(二甲基氨基)乙氧基]苯基]-5-(4-吡啶基)-1H-咪唑-4-基]-2,3-二氢-1-茚酮肟 (2E)-3-[2-丁基-1-[2-(二乙基氨基)乙基]-1H-苯并咪唑-5-基]-N-羟基丙烯酰胺 6-[2-(1,1-二甲基乙基)-5-(6-甲基-2-吡啶基)-1H-咪唑-4-基]喹喔啉 3-(4-氯苯基)-N-(3-甲氧基苯基)-2-丙烯酰胺 SB-705498 4-(4-氟苯基)-2-(4-甲基亚磺酰基苯基)-5-(4-吡啶基)-1H-咪唑 SB225002 4-[4-(4-氟苯基)-1-(4-哌啶基)-1H-咪唑-5-基]-2-甲氧基嘧啶 SB-505124